搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
2 小时
Why You May Need To Rethink Your Retirement, Work, And Spending
Living a long time in retirement with limited financial resources means you’ll need to be resourceful and creative to live ...
5 小时
How Well Do You Know Your Software Engineers' Security Skills?
As the industry continues to shift left and decentralize risk management responsibility, more and more of that responsibility ...
7 小时
CommScope: Refi Is Yet Another Temporary Fix, Reiterate Hold
CommScope shares moved up from $1.73 level by more than 250% to $5.70. Check out why I reiterate my Hold rating on COMM stock ...
8 小时
Humacyte surges on FDA approval for Symvess vascular repair product
Humacyte (HUMA) stock climbs as FDA approves Symvess, its implantable vascular conduit for arterial injury. Read more here.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈